APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Health Surgery Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal Health Surgery Drug Market Outlook and Growth Opportunities 2026

31 December 2025199 pages

Choose your research edition.

Industry ResearchAnimal Health Surgery Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Health Surgery Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Animal Health Surgery Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Health Surgery Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Health Surgery Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Animal Health Surgery Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal Health Surgery Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Health Surgery Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Health Surgery Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal Health Surgery Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal Health Surgery Drug market include Biogenesis Bago SA, Boehringer Ingelheim International GmbH., Ceva Santé Animale, Elanco Animal Health Incorporated, Merck Animal Health (Merck & Co., Inc.), NEOGEN Corporation., Piramal Group, Vetoquinol S.A. and Virbac S.A., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Animal Health Surgery Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Health Surgery Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Health Surgery Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Animal Health Surgery Drug market.

Animal Health Surgery Drug Segment by Company

Biogenesis Bago SA

Boehringer Ingelheim International GmbH.

Ceva Santé Animale

Elanco Animal Health Incorporated

Merck Animal Health (Merck & Co., Inc.)

NEOGEN Corporation.

Piramal Group

Vetoquinol S.A.

Virbac S.A.

Zoetis

Animal Health Surgery Drug Segment by Type

Anesthetics

Antibiotics

Opioids

Others

Animal Health Surgery Drug Segment by Application

Dental Surgery

Sterilization Surgery

Orthopedic Surgery

Others

Animal Health Surgery Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Animal Health Surgery Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Animal Health Surgery Drug key companies, revenue, market share, and recent developments.

3. To split the Animal Health Surgery Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Animal Health Surgery Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Health Surgery Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Health Surgery Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Health Surgery Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Health Surgery Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Health Surgery Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Health Surgery Drug industry.

Chapter 3: Detailed analysis of Animal Health Surgery Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Animal Health Surgery Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Animal Health Surgery Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Health Surgery Drug Industry Trends Table 2. Animal Health Surgery Drug Industry Drivers Table 3. Animal Health Surgery Drug Industry Opportunities and Challenges Table 4. Animal Health Surgery Drug Industry Restraints Table 5. Global Animal Health Surgery Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Health Surgery Drug Revenue Share by Company (2021-2026) Table 7. Global Animal Health Surgery Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Animal Health Surgery Drug Key Company Manufacturing Base & Headquarters Table 9. Global Animal Health Surgery Drug Company, Product Type & Application Table 10. Global Animal Health Surgery Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Animal Health Surgery Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Anesthetics Table 15. Significant Companies of Antibiotics Table 16. Significant Companies of Opioids Table 17. Significant Companies of Others Table 18. Global Animal Health Surgery Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Animal Health Surgery Drug Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Animal Health Surgery Drug Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Animal Health Surgery Drug Sales Value Share by Type (2021-2026) Table 22. Global Animal Health Surgery Drug Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Dental Surgery Table 24. Significant Companies of Sterilization Surgery Table 25. Significant Companies of Orthopedic Surgery Table 26. Significant Companies of Others Table 27. Global Animal Health Surgery Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Animal Health Surgery Drug Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Animal Health Surgery Drug Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Animal Health Surgery Drug Sales Value Share by Application (2021-2026) Table 31. Global Animal Health Surgery Drug Sales Value Share by Application (2027-2032) Table 32. Global Animal Health Surgery Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Animal Health Surgery Drug Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Animal Health Surgery Drug Sales Value Share by Region (2021-2026) Table 35. Global Animal Health Surgery Drug Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Animal Health Surgery Drug Sales Value Share by Region (2027-2032) Table 37. Global Animal Health Surgery Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Animal Health Surgery Drug Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Animal Health Surgery Drug Sales Value Market Share by Country (2021-2026) Table 40. Global Animal Health Surgery Drug Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Animal Health Surgery Drug Sales Value Market Share by Country (2027-2032) Table 42. Biogenesis Bago SA Company Information Table 43. Biogenesis Bago SA Business Overview Table 44. Biogenesis Bago SA Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Biogenesis Bago SA Animal Health Surgery Drug Product Portfolio Table 46. Biogenesis Bago SA Recent Development Table 47. Boehringer Ingelheim International GmbH. Company Information Table 48. Boehringer Ingelheim International GmbH. Business Overview Table 49. Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Product Portfolio Table 51. Boehringer Ingelheim International GmbH. Recent Development Table 52. Ceva Santé Animale Company Information Table 53. Ceva Santé Animale Business Overview Table 54. Ceva Santé Animale Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Ceva Santé Animale Animal Health Surgery Drug Product Portfolio Table 56. Ceva Santé Animale Recent Development Table 57. Elanco Animal Health Incorporated Company Information Table 58. Elanco Animal Health Incorporated Business Overview Table 59. Elanco Animal Health Incorporated Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Elanco Animal Health Incorporated Animal Health Surgery Drug Product Portfolio Table 61. Elanco Animal Health Incorporated Recent Development Table 62. Merck Animal Health (Merck & Co., Inc.) Company Information Table 63. Merck Animal Health (Merck & Co., Inc.) Business Overview Table 64. Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Product Portfolio Table 66. Merck Animal Health (Merck & Co., Inc.) Recent Development Table 67. NEOGEN Corporation. Company Information Table 68. NEOGEN Corporation. Business Overview Table 69. NEOGEN Corporation. Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. NEOGEN Corporation. Animal Health Surgery Drug Product Portfolio Table 71. NEOGEN Corporation. Recent Development Table 72. Piramal Group Company Information Table 73. Piramal Group Business Overview Table 74. Piramal Group Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Piramal Group Animal Health Surgery Drug Product Portfolio Table 76. Piramal Group Recent Development Table 77. Vetoquinol S.A. Company Information Table 78. Vetoquinol S.A. Business Overview Table 79. Vetoquinol S.A. Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Vetoquinol S.A. Animal Health Surgery Drug Product Portfolio Table 81. Vetoquinol S.A. Recent Development Table 82. Virbac S.A. Company Information Table 83. Virbac S.A. Business Overview Table 84. Virbac S.A. Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Virbac S.A. Animal Health Surgery Drug Product Portfolio Table 86. Virbac S.A. Recent Development Table 87. Zoetis Company Information Table 88. Zoetis Business Overview Table 89. Zoetis Animal Health Surgery Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Zoetis Animal Health Surgery Drug Product Portfolio Table 91. Zoetis Recent Development Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Animal Health Surgery Drug Product Image Figure 2. Global Animal Health Surgery Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Health Surgery Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Health Surgery Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Anesthetics Image Figure 8. Antibiotics Image Figure 9. Opioids Image Figure 10. Others Image Figure 11. Global Animal Health Surgery Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Animal Health Surgery Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Animal Health Surgery Drug Sales Value Share by Type (2021-2032) Figure 14. Dental Surgery Image Figure 15. Sterilization Surgery Image Figure 16. Orthopedic Surgery Image Figure 17. Others Image Figure 18. Global Animal Health Surgery Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Animal Health Surgery Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Animal Health Surgery Drug Sales Value Share by Application (2021-2032) Figure 21. Global Animal Health Surgery Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Animal Health Surgery Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Animal Health Surgery Drug Sales Value (2021-2032) & (US$ Million) Figure 24. North America Animal Health Surgery Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Animal Health Surgery Drug Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Animal Health Surgery Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Animal Health Surgery Drug Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Animal Health Surgery Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Animal Health Surgery Drug Sales Value (2021-2032) & (US$ Million) Figure 30. South America Animal Health Surgery Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Animal Health Surgery Drug Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Animal Health Surgery Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Animal Health Surgery Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Anesthetics
  • Antibiotics
  • Opioids
  • Others
Applications
  • Dental Surgery
  • Sterilization Surgery
  • Orthopedic Surgery
  • Others
Companies covered
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH.
  • Ceva Santé Animale
  • Elanco Animal Health Incorporated
  • Merck Animal Health (Merck & Co., Inc.)
  • NEOGEN Corporation.
  • Piramal Group
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Animal Health Surgery Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Animal Health Surgery Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Animal Health Surgery Drug Market Dynamics
  1. 2.1 Animal Health Surgery Drug Industry Trends
  2. 2.2 Animal Health Surgery Drug Industry Drivers
  3. 2.3 Animal Health Surgery Drug Industry Opportunities and Challenges
  4. 2.4 Animal Health Surgery Drug Industry Restraints
3 Animal Health Surgery Drug Market by Company
  1. 3.1 Global Animal Health Surgery Drug Company Revenue Ranking in 2025
  2. 3.2 Global Animal Health Surgery Drug Revenue by Company (2021-2026)
  3. 3.3 Global Animal Health Surgery Drug Company Ranking (2024-2026)
  4. 3.4 Global Animal Health Surgery Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Animal Health Surgery Drug Company Product Type and Application
  6. 3.6 Global Animal Health Surgery Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Animal Health Surgery Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Animal Health Surgery Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Animal Health Surgery Drug Market by Type
  1. 4.1 Animal Health Surgery Drug Type Introduction
  2. 4.1.1 Anesthetics
  3. 4.1.2 Antibiotics
  4. 4.1.3 Opioids
  5. 4.1.4 Others
  6. 4.2 Global Animal Health Surgery Drug Sales Value by Type
  7. 4.2.1 Global Animal Health Surgery Drug Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Animal Health Surgery Drug Sales Value by Type (2021-2032)
  9. 4.2.3 Global Animal Health Surgery Drug Sales Value Share by Type (2021-2032)
5 Animal Health Surgery Drug Market by Application
  1. 5.1 Animal Health Surgery Drug Application Introduction
  2. 5.1.1 Dental Surgery
  3. 5.1.2 Sterilization Surgery
  4. 5.1.3 Orthopedic Surgery
  5. 5.1.4 Others
  6. 5.2 Global Animal Health Surgery Drug Sales Value by Application
  7. 5.2.1 Global Animal Health Surgery Drug Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Animal Health Surgery Drug Sales Value by Application (2021-2032)
  9. 5.2.3 Global Animal Health Surgery Drug Sales Value Share by Application (2021-2032)
6 Animal Health Surgery Drug Regional Value Analysis
  1. 6.1 Global Animal Health Surgery Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Health Surgery Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Animal Health Surgery Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Animal Health Surgery Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Animal Health Surgery Drug Sales Value (2021-2032)
  7. 6.3.2 North America Animal Health Surgery Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Animal Health Surgery Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Animal Health Surgery Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Animal Health Surgery Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Animal Health Surgery Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Animal Health Surgery Drug Sales Value (2021-2032)
  16. 6.6.2 South America Animal Health Surgery Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Animal Health Surgery Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Animal Health Surgery Drug Sales Value Share by Country, 2025 VS 2032
7 Animal Health Surgery Drug Country-level Value Analysis
  1. 7.1 Global Animal Health Surgery Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Health Surgery Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Animal Health Surgery Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Animal Health Surgery Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Animal Health Surgery Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Animal Health Surgery Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Animal Health Surgery Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogenesis Bago SA
  2. 8.1.1 Biogenesis Bago SA Company Information
  3. 8.1.2 Biogenesis Bago SA Business Overview
  4. 8.1.3 Biogenesis Bago SA Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogenesis Bago SA Animal Health Surgery Drug Product Portfolio
  6. 8.1.5 Biogenesis Bago SA Recent Developments
  7. 8.2 Boehringer Ingelheim International GmbH.
  8. 8.2.1 Boehringer Ingelheim International GmbH. Company Information
  9. 8.2.2 Boehringer Ingelheim International GmbH. Business Overview
  10. 8.2.3 Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim International GmbH. Animal Health Surgery Drug Product Portfolio
  12. 8.2.5 Boehringer Ingelheim International GmbH. Recent Developments
  13. 8.3 Ceva Santé Animale
  14. 8.3.1 Ceva Santé Animale Company Information
  15. 8.3.2 Ceva Santé Animale Business Overview
  16. 8.3.3 Ceva Santé Animale Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ceva Santé Animale Animal Health Surgery Drug Product Portfolio
  18. 8.3.5 Ceva Santé Animale Recent Developments
  19. 8.4 Elanco Animal Health Incorporated
  20. 8.4.1 Elanco Animal Health Incorporated Company Information
  21. 8.4.2 Elanco Animal Health Incorporated Business Overview
  22. 8.4.3 Elanco Animal Health Incorporated Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Animal Health Incorporated Animal Health Surgery Drug Product Portfolio
  24. 8.4.5 Elanco Animal Health Incorporated Recent Developments
  25. 8.5 Merck Animal Health (Merck & Co., Inc.)
  26. 8.5.1 Merck Animal Health (Merck & Co., Inc.) Company Information
  27. 8.5.2 Merck Animal Health (Merck & Co., Inc.) Business Overview
  28. 8.5.3 Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Animal Health (Merck & Co., Inc.) Animal Health Surgery Drug Product Portfolio
  30. 8.5.5 Merck Animal Health (Merck & Co., Inc.) Recent Developments
  31. 8.6 NEOGEN Corporation.
  32. 8.6.1 NEOGEN Corporation. Company Information
  33. 8.6.2 NEOGEN Corporation. Business Overview
  34. 8.6.3 NEOGEN Corporation. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NEOGEN Corporation. Animal Health Surgery Drug Product Portfolio
  36. 8.6.5 NEOGEN Corporation. Recent Developments
  37. 8.7 Piramal Group
  38. 8.7.1 Piramal Group Company Information
  39. 8.7.2 Piramal Group Business Overview
  40. 8.7.3 Piramal Group Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Piramal Group Animal Health Surgery Drug Product Portfolio
  42. 8.7.5 Piramal Group Recent Developments
  43. 8.8 Vetoquinol S.A.
  44. 8.8.1 Vetoquinol S.A. Company Information
  45. 8.8.2 Vetoquinol S.A. Business Overview
  46. 8.8.3 Vetoquinol S.A. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vetoquinol S.A. Animal Health Surgery Drug Product Portfolio
  48. 8.8.5 Vetoquinol S.A. Recent Developments
  49. 8.9 Virbac S.A.
  50. 8.9.1 Virbac S.A. Company Information
  51. 8.9.2 Virbac S.A. Business Overview
  52. 8.9.3 Virbac S.A. Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Virbac S.A. Animal Health Surgery Drug Product Portfolio
  54. 8.9.5 Virbac S.A. Recent Developments
  55. 8.10 Zoetis
  56. 8.10.1 Zoetis Company Information
  57. 8.10.2 Zoetis Business Overview
  58. 8.10.3 Zoetis Animal Health Surgery Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Zoetis Animal Health Surgery Drug Product Portfolio
  60. 8.10.5 Zoetis Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst